Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Cancer Vaccines
- Language: English
- Published: March 2013
"Analytical Tool - Pancreatic Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in pancreatic cancer R&D and business development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.
Included in this advantageous package are two products already appreciated by many of our customers:
Commercializing Pancreatic Cancer Drugs: The Faster Route to Consider Your Options and Position of Others
Pancreatic Cancer Drug Pipeline Update 2013*.
The Package Includes
- A progress analysis on current and emerging drugs
- Information on
READ MORE >
| Format | Properties | |
|---|---|---|
| Electronic (Online Access) | The report will be emailed to you. Online access is provided for this product. | This is a single user license, allowing one specific user access to the product. |